E Kunieda Selected Research

ErbB Receptors (EGF Receptor)

1/2012

An analysis of the survival rate after radiotherapy in lung cancer patients with bone metastasis: is there an optimal subgroup to be treated with high-dose radiation therapy?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Kunieda Research Topics

Disease

2	Neoplasms (Cancer) 11/2019 - 12/2008
1	Hypesthesia (Numbness) 01/2012
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Neoplasm Metastasis (Metastasis) 01/2012
1	Adenocarcinoma 01/2012
1	Pain (Aches) 01/2012
1	Paresis (Hemiparesis) 01/2012
1	Scoliosis 01/2010
1	Congenital Abnormalities (Deformity) 01/2010
1	Brain Neoplasms (Brain Tumor) 12/2008

Drug/Important Bio-Agent (IBA)

1	ErbB Receptors (EGF Receptor)IBA 01/2012
1	GadoliniumIBA 12/2008

Therapy/Procedure

4	Radiotherapy 11/2019 - 12/2008
1	Nephrectomy 01/2010